Phase I/II Trial of S64315 Plus Azacitidine in Acute Myeloid Leukaemia
Status:
Recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability and clinical activity of the
combination S64315 with azacitidine in patients with acute myeloid leukaemia.